INTERNATIONAL PATENT: NOVAREMED AG FILES APPLICATION FOR "(S,S)-(3-O-(PROPAN-2-OL)-2-AMINO-PROP-1-YL-4-HYDROXYBENZENE AND ITS ANALOGUES FOR THE TREATMENT OF CHRONIC PAIN"

GENEVA, Feb. 23 -- NOVAREMED AG (Thiersteinerallee 174053 Basel) filed a patent application (PCT/EP2024/072738) for "(S,S)-(3-O-(PROPAN-2-OL)-2-AMINO-PROP-1-YL-4-HYDROXYBENZENE AND ITS ANALOGUES FOR THE TREATMENT OF CHRONIC PAIN" on Aug 12, 2024. With publication no. WO/2026/037478, the details related to the patent application was published on Feb 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KAPLAN, Eliahu (c/o Novaremed AGThiersteinerallee 174053 Basel)

Abstract: The present invention relates to a compound of formula (I) or its pharmaceutically acceptable salt. The compound of form...